`
`portal.uspto.gov/pair/PAIRPrintServlet
`
`ENHANCEMENT OF PHARMACEUTICAL ACTIVITY
` 06/633,481
` Bibliographic Data
`Application Number:
`
`06/633,481
`
`Filing or 371 (c) Date: 07-26-1984
`Application Type:
`Utility
`Examiner Name:
`WEDDINGTON, KEVIN E
`Group Art Unit:
`1205
`Confirmation Number: 9880
`Attorney Docket
`Number:
`424/450
`Class / Subclass:
`First Named Inventor: MICHAEL W. FOUNTAIN ,
`PRINCETON, NJ (US)
`
`2349-056
`
`First named Applicant: -
`
`Entity Status:
`
`Undiscounted
`
`AIA (First Inventor to
`File):
`
`No
`
`2349-056
`
`05-01-
`2017::18:39:11
`
`-
`
`Patented Case
`01-17-1991
`FILE REPOSITORY (FRANCONIA)
`09-10-2002
`-
`
`-
`
`5,000,958
`
`Correspondence Address
`Customer Number:
`Status:
`Status Date:
`Location:
`Location Date:
`Earliest Publication No:
`Earliest Publication
`Date:
`Patent Number:
`
`Issue Date of Patent:
`
`03-19-1991
`
`International
`Registration Number
`(Hague):
`International
`Registration Publication
`Date:
`
`-
`
`-
`
`Title of Invention:
`
`ENHANCEMENT OF PHARMACEUTICAL ACTIVITY
`
`Close Window
`
`http://portal.uspto.gov/pair/PAIRPrintServlet
`
`1/1
`
`Apotex v. Novartis
`IPR2017-00854
`NOVARTIS 2019
`
`